180 results on '"Thompson, Gilbert A."'
Search Results
2. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
3. FH through the retrospectoscope
4. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017
5. Use of apheresis in the age of new therapies for familial hypercholesterolaemia
6. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans
7. The future of clinical lipidology in the UK
8. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
9. Current Role of Lipoprotein Apheresis
10. Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes
11. In Memoriam: Nick Myant (1917–2015)
12. Managing homozygous familial hypercholesterolaemia from cradle to grave
13. The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease
14. Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances
15. Is Good Cholesterol Always Good? Genetic And Pharmacological Increases Of Hdl Cholesterol Need Further Evaluation
16. Efficacy criteria and cholesterol targets for LDL apheresis
17. Cholesterol Lowering Margarine Is Effective
18. Defects of Receptor-Mediated Low Density Lipoprotein Catabolism in Homozygous Familial Hypercholesterolemia and Hypothyroidism in vivo
19. Difference in Saturable Binding of Low Density Lipoprotein to Liver Membranes from Normocholesterolemic Subjects and Patients with Heterozygous Familial Hypercholesterolemia
20. An Indian Dance at Jemez, New Mexico
21. Use of Statins
22. Lipoprotein(a): the underestimated cardiovascular risk factor
23. Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasis
24. Measurement of the Reflectivity of the Intima-Medial Layer of the Common Carotid Artery Improves the Discriminatory Value of Intima-Medial Thickness Measurement as a Predictor of Risk of Atherosclerotic Disease
25. Management of hyperlipidemia in the pediatric population
26. Lipoprotein apheresis for the treatment of familial hypercholesterolemia
27. Goals of statin therapy: Three viewpoints
28. Lipoprotein apheresis
29. Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
30. Which lipid fraction is the target and how often should this be monitored?
31. Comparison of Efficacy of Plant Stanol Ester and Sterol Ester: Short-Term and Longer-Term Studies
32. Additive Effects of Plant Sterol and Stanol Esters to Statin Therapy
33. History and Development of Plant Sterol and Stanol Esters for Cholesterol-Lowering Purposes
34. Current management of severe homozygous hypercholesterolaemias
35. Management of dyslipidaemia
36. Screening relatives of patients with premature coronary heart disease
37. LDL apheresis
38. Therapeutic approaches to reducing the LDL- and HDL-associated risks of coronary heart disease
39. Clinical lipidology at the end of the millennium
40. The proving of the lipid hypothesis
41. Use of statins: Sheffield tables have shortcomings
42. Traitement heroique?
43. First priority is to decrease the severity of hyperchylomicronaemia
44. Limitations of cholesterol lowering with PCSK9 inhibitors
45. Statins and coronary heart disease
46. Lipid lowering in the young
47. Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease
48. Angiographic trials of lipid-lowering therapy: end of an era?
49. Low-density-lipoprotein apheresis
50. Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.